What Researchers Did
Researchers conducted a prospective randomized study on 41 patients with hepatocellular carcinoma (HCC) who underwent partial hepatectomy to evaluate if early postoperative hyperbaric oxygen therapy (HBOT) could reduce the need for blood transfusions.
What They Found
In six HBOT patients experiencing major bleeding or hepatic hypoxia, ShvO2 and serum lactate levels significantly improved after treatment. The HBOT group demonstrated better changes in ShvO2, serum lactate, and bilirubin levels over the first three postoperative days compared to the control group, with no fatal complications observed.
What This Means for Canadian Patients
This study suggests that HBOT might be a beneficial intervention for Canadian patients with HCC undergoing liver resection, potentially reducing the need for blood transfusions and improving early postoperative recovery. If validated in larger studies, HBOT could offer a new strategy to manage postoperative complications and enhance outcomes for these patients.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in a different country.
Study Limitations
A key limitation of this study is its relatively small sample size of 41 patients, which may limit the generalizability of the findings.